Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth-Reference-Cited by-同舟云学术

Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth

Published:2013-02 Issue:1 Volume:329 Page:74-83
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

van Malenstein Hannah,Dekervel Jeroen,Verslype Chris,Van Cutsem Eric,Windmolders Petra,Nevens Frederik,van Pelt Jos

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference56 articles.

1. D.M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics, 2002 CA, Cancer J. Clin. 55 (2005) 74–108.

2. Hepatocellular carcinoma;Llovet;Lancet,2003

3. Design and endpoints of clinical trials in hepatocellular carcinoma;Llovet;J. Nat. Cancer. Inst.,2008

4. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis;Wilhelm;Cancer Res.,2004

5. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5;Liu;Cancer Res.,2006

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma;Frontiers in Immunology;2024-05-29

2. Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma;Drug Resistance Updates;2024-05

3. Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma;Cancer Cell International;2024-04-16

4. Aldehyde Dehydrogenase 2 (ALDH2): A novel sorafenib target in hepatocellular carcinoma unraveled by the proteome-wide cellular thermal shift assay;SLAS Discovery;2024-04

5. The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy;International Journal of Molecular Sciences;2024-01-11